The Endothelial Storm: Decoding Orthohantavirus Pathophysiology, History, and the 2026 Shift
Senior Clinical Respiratory Scientist
RRT-ACCS | RRT-NPS | RRT-PFT • 20+ Yrs Experience
If you’ve spent any time managing complex respiratory failure in the ICU or evaluating complex loops in the PFT lab, you know that not all acute respiratory distress syndromes (ARDS) are created equal. As respiratory therapists, we are often trained to view bilateral infiltrates and refractory hypoxemia through a standardized ARDSnet lens.
However, the recent 2026 hantavirus cluster on the MV Hondius cruise ship has pulled a notoriously lethal group of pathogens back into the clinical spotlight: the New World Orthohantaviruses, specifically the Andes strain (ANDV).
To truly understand how to intervene and save these patients, we have to look past the surface-level diagnostics. We must examine the precise flow dynamics, molecular pathogenesis, and historical milestones that define our modern clinical approach.
01. A Brief History of Discovery: From HFRS to HPS
Our understanding of orthohantaviruses has undergone a dramatic paradigm shift over the last several decades. For a long time, hantaviruses were viewed almost exclusively through an Eastern Hemisphere lens. During the Korean War in the 1950s, thousands of soldiers fell ill with a mysterious hemorrhagic illness. It wasn’t until 1978 that Dr. Ho Wang Lee isolated the Hantaan virus from the striped field mouse (Apodemus agrarius), defining the paradigm of Hemorrhagic Fever with Renal Syndrome (HFRS). This “Old World” virus primarily targets the renal vasculature, carrying a case fatality rate of 5% to 15%.
The global clinical playbook changed permanently in 1993 during the Four Corners outbreak in the southwestern United States. Healthy young individuals were rapidly dying of explosive, non-cardiogenic pulmonary edema. Investigators isolated the Sin Nombre Virus (SNV), carried by the deer mouse (Peromyscus maniculatus), and coined a new clinical entity: Hantavirus Pulmonary Syndrome (HPS).
Soon after, South American surveillance identified the Andes virus (ANDV). The Andes strain added a terrifying evolutionary twist: it is the only orthohantavirus with definitive, peer-reviewed evidence of human-to-human “silent transmission” via saliva and respiratory secretions. This completely upended the traditional environmental-exposure-only isolation models.
02. The RNA Virology Refresher
To understand the therapy, we must understand the virus’s core machinery. Orthohantaviruses are enveloped, negative-sense, single-stranded RNA viruses (ssRNA).
Unlike positive-sense RNA viruses (such as Coronaviruses), which host ribosomes can instantly translate upon entry, negative-sense viruses face a structural hurdle. They must pack their own viral RNA-dependent RNA polymerase (RdRp) within the virion to synthesize positive-sense mRNA templates before host translation can occur.
Current Trends in Translational Science Targeting this Replication Bottleneck:
- • Broad-Spectrum Nucleoside Analogs: Drugs like favipiravir actively disrupt the viral RdRp, terminating the RNA chain prematurely.
- • Stable mRNA Vaccines & Passive Antibodies: Moving past traditional inactivated vaccines, current research focuses on glycoprotein-based mRNA platforms and human polyclonal antibody preparations (such as SAB-163), which provide critical post-exposure prophylaxis in animal models.
03. The Crucial Contrast: Hantavirus vs. Coronavirus
When SARS-CoV-2 emerged, the respiratory care community became experts in epithelial damage. Coronaviruses are inherently cytopathic. They directly bind to ACE2 receptors on Type I and Type II pneumocytes, replicate aggressively, and destroy the alveolar architecture. This leads to a dense, cellular, proteinaceous exudate, hyaline membrane formation, and structural alveolar collapse.
Hantavirus operates under a completely different physiological mechanism: it is non-cytopathic.
The virus enters the bloodstream and targets endothelial cells, specifically binding to β3 integrins and the clade-specific host factor, Protocadherin-1 (PCDH1). Instead of destroying the cells, the viral Gn/Gc glycoproteins trigger an intense host immune response. This provokes a massive, hyper-permeable endothelial fluid shift.
The plumbing leaks, but the walls remain intact. The alveolar space is instantly flooded with a low-protein clear transudate, leaving the underlying epithelium structurally undamaged. This distinction is vital for RTs: if you can bridge a hantavirus patient through the acute fluid storm, their potential for complete, unscarred lung recovery is exceptionally high.
04. Flow Dynamics & Diagnostic Accuracy: The 2026 PFT Filter
When monitoring survivors of severe HPS in the pulmonary function laboratory, our diagnostic metrics must meet the highest contemporary evidence standards.
Any study or clinical report utilizing outdated “Percent Predicted” models without referencing the Global Lung Function Initiative (GLI) equations or z-scores must be flagged as low-quality data. Relying on fixed cutoffs (like the arbitrary 80% predicted rule) misclassifies patient severity, especially at the extremes of age and stature, and fails to account for normal population variance. Per the latest ATS/ERS 2026 Technical Standards, abnormality must be defined exclusively by a z-score below the Lower Limit of Normal (LLN, -1.64).
In post-HPS clinical follow-ups, we focus heavily on three areas:
Flow-Volume Loop Morphology
Post-acute fluid accumulation can cause residual interstitial changes. On a forced expiratory maneuver, look for a tall, narrow loop characteristic of restriction (where FVC is reduced, but the FEV1/FVC ratio remains normal or elevated), as opposed to the scooped expiratory limb seen in obstructive etiologies like geriatric COPD.
Gas Exchange & DLCO QC
Evaluating the diffusing capacity (DLCO) is our best window into the status of the alveolar-capillary membrane. However, because HPS patients endure profound fluid shifts and frequent micro-hemorrhagic events, all DLCO measurements must be strictly adjusted for current hemoglobin (Hb) levels. A raw DLCO without an Hb correction provides an inaccurate assessment.
Impulse Oscillometry (IOS)
For pediatric patients or weak geriatrics unable to perform a valid, repeatable forced expiratory maneuver, we utilize IOS. By superimposing sound waves during normal tidal breathing, IOS measures total airway resistance (Raw) and reactance (Xaw), isolating peripheral small airway impairment.